Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use ...

Weight-loss drugs have also now been added to the list of “high-risk” medicines requiring extra safeguards. If pharmacists do ...

Novo Nordisk boasts 45 million customers using its drug, which has caused a revolution in weight-loss treatment. But competitors are nipping at its heels.

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...

Previously, the drugs were able to be prescribed through an email chat, from questionnaires or by people sending in photos of ...

Pharmacy regulator warns some people with history of eating disorders wrongly obtaining medicines such as Wegovy or Mounjaro ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Weight loss injections are prescription medications to help with weight loss. They can help alter a person’s appetite and metabolism, curbing hunger and reducing calorie intake. Weight loss ...